Latisse Faces Patent Challenge
The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version. (Source: WSJ.com: Health)
More here:
Latisse Faces Patent Challenge
Latisse Faces Patent Challenge
The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version.
Read the original post:
Latisse Faces Patent Challenge
Latisse Faces Patent Challenge
The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version.
See the original post:
Latisse Faces Patent Challenge
FDA OKs 1st Eyelash Drug Latisse
Title: FDA OKs 1st Eyelash Drug LatisseCategory: Health NewsCreated: 12/29/2008Last Editorial Review: 12/29/2008 (Source: MedicineNet Eyesight General) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network , and receive $5 free advertising.
Continue reading here:
FDA OKs 1st Eyelash Drug Latisse
Epione Beverly Hills- Revolutionary New Sunblock Formula ‘Protects and Corrects’
- Epione Beverly Hills Helps Kick Off 2010 Teen Choice Awards’ Festivities with KIIS FM
- Beverly Hills Leader in Cosmetic Procedures Earns Allergan’s Highest Level of Recognition
- Dr. Simon Ourian to Offer Industry Expertise to Medicis
- The Cast of ‘Jersey Shore’ Learns Safe Tanning Tips and Secrets from Epione Beverly Hills
- Image is Everything: Three Aesthetic Treatments for Building Confidence and Looking and Feeling Your Best
- Why More Women are Choosing OptiLipo over Liposuction
- Say “Adios” to Acne Scars
- New Laser Treatment Offers Revolutionary Response to Aesthetic Procedure Candidates’ Number One Concern: Recovery Time
- Epione Reveals a “Bright” New Solution for Dull, Sun Damaged Skin